Impact of repeat revascularization within 5 years on 10-year mortality after percutaneous or surgical

Rutao Wang1,2,3, Mattia Lunardi4,5, Hironori Hara2,6

  • 1Department of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.

Insights

Repeat revascularization within 5 years did not impact overall 10-year mortality for patients with complex coronary artery disease. However, those needing repeat procedures after initial PCI faced higher mortality than after CABG.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Clinical Trials

Background:

  • The SYNTAX trial indicated repeat revascularization (RR) negatively impacts 5-year outcomes in 3-vessel disease (3VD) and/or left main coronary artery disease (LMCAD).
  • The SYNTAXES study aimed to assess the 10-year mortality impact of RR within 5 years in these patients.

Purpose of the Study:

  • To evaluate the effect of repeat revascularization within 5 years on 10-year all-cause mortality.
  • To compare outcomes between Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting (CABG) in patients requiring repeat procedures.

Main Methods:

  • The SYNTAXES study analyzed 10-year vital status data from patients with 3VD and/or LMCAD.
  • Patients were stratified based on whether they underwent repeat revascularization within 5 years and their initial randomized treatment (PCI vs. CABG).
  • Statistical analysis assessed the association between repeat revascularization and 10-year mortality.

Main Results:

  • 18.3% of patients underwent repeat revascularization within 5 years; it was more frequent after initial PCI (25.9%) than CABG (13.7%).
  • Overall 10-year mortality was similar between patients with and without repeat revascularization (28.2% vs. 26.1%).
  • Among patients requiring repeat procedures, initial PCI was associated with higher 10-year mortality (33.5%) compared to initial CABG (17.6%, adjusted HR: 2.09).

Conclusions:

  • Repeat revascularization within 5 years did not significantly impact overall 10-year mortality in the studied population.
  • For patients requiring repeat procedures, initial PCI was linked to a higher risk of 10-year mortality compared to initial CABG.
  • Further investigation in larger cohorts is warranted to confirm these exploratory findings.
Abstract

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
14
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
14
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
13